Floatz logo

ONC 206

Pilocytic Astrocytoma

Jazz PharmaceuticalsSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Pilocytic Astrocytoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Novartis Pharmaceuticals
Phase 2BB
Carboplatin
Novartis Pharmaceuticals
Phase 2BB
Dabrafenib
Novartis Pharmaceuticals
Phase 4BB
gsk1120212
Novartis Pharmaceuticals
Phase 4BB
ETOPOSIDE
Washington University School of Medicine
Phase 2CCC

View all 17 →

Same molecule, other indications

ONC 206 is also rated in:

grade II meningiomaDormant
CC
Indicative ·
43 / 100
View asset →
ependymomaDormant
CC
Indicative ·
43 / 100
View asset →
central nervous system cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →